» Articles » PMID: 8593014

Antibacterial Action of Ciprofloxacin

Overview
Specialty Pharmacology
Date 1995 Dec 1
PMID 8593014
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanisms by which quinolones rapidly kill are ill defined. We have investigated the action of ciprofloxacin on Escherichia coli KL16 with a combination of traditional and flow cytometric methods and have analyzed cells for changes in membrane potential, membrane integrity, oxidative metabolism, morphology, and viability. Log-phase cultures were exposed to various concentrations (0.1, 1, 10, and 100 times the MIC) of ciprofloxacin and analyzed at regular intervals over 120 min. We also measured protein synthesis in the related strain PQ37 cultured under the same conditions over 300 min, using a colorimetric assay for beta-galactosidase release. Despite a 3-log order decrease in CFU after 60-min exposure to 10 and 100 times the MIC of ciprofloxacin, there was no equivalent decrease in bacterial numbers as determined by both light microscopy and flow cytometry. Furthermore, while these bacteria showed concentration-dependent morphological changes, most were capable not only of excluding the fluorescent nucleic acid-binding dye propidium iodide, but also of reducing the tetrazolium dye cyanoditodyl tetrazolium chloride. Over 90% of the bacteria maintained a membrane potential [as determined by exclusion of bis-[1,3-dibutylbarbituric acid) trimethine oxonol] when exposed to ciprofloxacin for 120 min, except at 100 times the MIC, when this figure fell to < 10%. Finally, protein synthesis was either maintained or induced at all concentrations of ciprofloxacin up to 5 h postexposure. Taken together, these results demonstrate the continuing physical and metabolic survival of ciprofloxacin-exposed bacteria; we suggest parallels with the concept of the viable nonculturable state.

Citing Articles

Click chemistry-enabled gold nanorods for sensitive detection and viability evaluation of copper(II)-reducing bacteria.

Tian T, Yang W, Wang X, Liu T, Pan B, Guo W Mater Today Bio. 2025; 30:101453.

PMID: 39866790 PMC: 11764086. DOI: 10.1016/j.mtbio.2025.101453.


Chromatin inspired bio-condensation between biomass DNA and guanosine monophosphate produces all-nucleic hydrogel as a hydrotropic drug carrier.

Sarma S, Thakur N, Varshney N, Jha H, Sarma T Commun Chem. 2024; 7(1):261.

PMID: 39533097 PMC: 11557961. DOI: 10.1038/s42004-024-01353-6.


Dysregulated NAD(H) homeostasis associated with ciprofloxacin tolerance in investigated on a single-cell level with the Peredox [NADH:NAD+] biosensor.

Urbaniec J, Sanderson-Smith M, McFadden J, Hai F, Hingley-Wilson S Front Microbiol. 2023; 14:1191968.

PMID: 37415820 PMC: 10321300. DOI: 10.3389/fmicb.2023.1191968.


Enhancement of Magnetic Surface-Enhanced Raman Scattering Detection by Tailoring FeO@Au Nanorod Shell Thickness and Its Application in the On-site Detection of Antibiotics in Water.

Berganza L, Litti L, Meneghetti M, Lanceros-Mendez S, Reguera J ACS Omega. 2022; 7(49):45493-45503.

PMID: 36530269 PMC: 9753213. DOI: 10.1021/acsomega.2c06099.


A Phage Receptor-Binding Protein as a Promising Tool for the Detection of in Human Specimens.

Costa S, Cunha A, Freitas P, Carvalho C Front Microbiol. 2022; 13:871855.

PMID: 35722298 PMC: 9202026. DOI: 10.3389/fmicb.2022.871855.


References
1.
Hane M, Wood T . Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies. J Bacteriol. 1969; 99(1):238-41. PMC: 249993. DOI: 10.1128/jb.99.1.238-241.1969. View

2.
Crumplin G, Smith J . Nalidixic acid: an antibacterial paradox. Antimicrob Agents Chemother. 1975; 8(3):251-61. PMC: 429302. DOI: 10.1128/AAC.8.3.251. View

3.
Sugino A, Peebles C, Kreuzer K, Cozzarelli N . Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci U S A. 1977; 74(11):4767-71. PMC: 432036. DOI: 10.1073/pnas.74.11.4767. View

4.
Gellert M, Mizuuchi K, ODea M, Itoh T, TOMIZAWA J . Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Natl Acad Sci U S A. 1977; 74(11):4772-6. PMC: 432037. DOI: 10.1073/pnas.74.11.4772. View

5.
Roszak D, Grimes D, Colwell R . Viable but nonrecoverable stage of Salmonella enteritidis in aquatic systems. Can J Microbiol. 1984; 30(3):334-8. DOI: 10.1139/m84-049. View